‘Natalizumab in paediatric multiple sclerosis and service implication’-Reference-Cited by-同舟云学术

‘Natalizumab in paediatric multiple sclerosis and service implication’

Published:2009-09 Issue:9 Volume:51 Page:758-759
ISSN:0012-1622
Container-title:Developmental Medicine & Child Neurology
language:en
Short-container-title:

Author:

Appleton Richard E,Boggild Mike

Publisher

Wiley

Subject

Clinical Neurology,Developmental Neuroscience,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1469-8749.2009.03378.x/fullpdf

Reference10 articles.

1. Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis;Karenfort;Dev Med Child Neurol,2009

2. Multiple sclerosis in children under 6 years of age;Ruggieri;Neurology,1999

3. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis;Gorman;Arch Neurol,2009

5. 5.National Institute for Clinical Excellence. Beta Interferon and Glatiramer Acetate for the Treatment of Multiple Sclerosis: Technology Appraisal Number 32, 2002. http://www.nice.org.uk (accessed November 2008).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS;Neurology - Neuroimmunology Neuroinflammation;2019-07-01

2. Treatment of pediatric multiple sclerosis;Personalized Management of Multiple Sclerosis;2013-07

3. Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases;Multiple Sclerosis Journal;2013-02-11

4. Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis;European Journal of Paediatric Neurology;2013-01

5. Best practice in the use of natalizumab in multiple sclerosis;Therapeutic Advances in Neurological Disorders;2012-12-20